Académique Documents
Professionnel Documents
Culture Documents
SYNDROME
Aarthi V
Roshan Kollipara
Aparna Nair
Case outline
28 y/o male presented with chief complaint of chest pain, which started at 9
am that day. Patient refers that he had a sudden onset of central chest
pain(6/10) along with 2 episodes of vomiting.
- unstable angina
- Non ST elevation Myocardial Infarction(NSTEMI)
- ST elevation Myocardial Infarction(STEMI)
NOTE: Pain may be absent in patients with prior stroke, age>75 and those
with DM. Painless MI is more common in females.
NSTEMI
T wave inversion
May show pathological Q waves after a few hours. This suggests that MI has
fully evolved and there is a full thickness infarct.
Myoglobin
Cardiac Troponins
Cardiac MRI
MI can be accurately detected with high resolution cardiac MRI using a
technique called late enhancement.
Chest X-ray
May show evidence of pulmonary edema.
Heart size is usually normal but there may be cardiomegaly due to previous
myocardial damage or pericardial effusion.
Other Investigations
● Leukocytosis with a peak on the first day
● ESR will be raised and may remain so for days.
● Raised CRP
● H-FABP (Heart type fatty acid binding protein) as a plasma marker for the
diagnosis of patients presenting with chest pain suggestive of MI.
● Renal function tests
● Serum electrolytes
● Serum glucose and lipid profile.
Treatment of ACS
When looking into treatment of ACS, treatment varies based on the type
of ACS being handled. In case of unstable angina and NSTEMI- treatment
can be categorized as follows:
- Anti-ischemic drugs
- Anti- thrombotic drugs
- Plaque stabilizing drugs
- Pain relief and prophylaxis
1. Nitrates
2. Beta blockers
3. Calcium channel blockers
4. Oxygen
2.Anti- Thrombotic drugs
1. Anti-platelet drugs like Aspirin and P2Y12 receptor antagonists like
clopidogrel.
2. Anticoagulant drugs like:
a. Unfractionated heparin
b. Low molecular weight heparin
c. Direct Thrombin inhibitors like
d. Direct factor Xa inhibitors like fondaparinux
3. Plaque stabilizing drugs
ACE inhibitors
- Prophylaxis against further such events is by the use of all the above
mentioned drugs to minimize the risk of development of thrombi/
impaired perfusion. To this list of prophylactic drugs- statins can be
added.
STEMI management
Emergency interventions
In case of STEMI management- the major difference lies in the emergency
interventions that need to be done.
Medium risk to high risk: Treat with multidrug therapy and early coronary
angiography and appropriate surgical intervention.
Minimize “door- to- balloon time”
In patients that have presented with STEMI to the hospital, with or without
thrombolysis- percutaneous intervention should ideally be done as soon as
possible.